Double high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation for primary disseminated medulloblastoma: A report of 3 cases

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages e70-e74

  Aihara, Yasuo ^a   Tsuruta, Toshihisa ^b   Kawamata, Takakazu ^a   Kanno, Hitoshi ^a   Maebayashi, Katsuya ^a   Sakauchi, Masako ^a   Wada, Emiko ^c   Osawa, Makiko ^a   Fujii, Hisaichi ^a   Kubo, Osami ^a   Hori, Tomokatsu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Dissemination; High dose chemotherapy; Medulloblastoma; PCR; Stem cell transplantation

Indexed keywords

CARBOPLATIN; DIURETIC AGENT; ETOPOSIDE; GADOLINIUM; IFOSFAMIDE; MELPHALAN; THIOTEPA; ULINASTATIN; VINCRISTINE;

ADOLESCENT; ANAMNESIS; ANOREXIA; APHASIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; CHILD; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; FEBRILE NEUTROPENIA; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LIVER VEIN OBSTRUCTION; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL CORD METASTASIS; STEM CELL TRANSPLANTATION; STOMATITIS; TUMOR VOLUME; VIRUS ONCOGENE; VOMITING;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CEREBELLAR NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; HUMANS; MALE; MEDULLOBLASTOMA; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECEPTOR, ERBB-2; TRANSPLANTATION, AUTOLOGOUS;

EID: 77949467486     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181c46b92     Document Type: Article

References (23)

1. Laurent JP, Chang CH, Cohen ME. A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer. 1985;56(suppl 7): 1807-1809.
2. Jenkin D, Shabanah MA, Shail EA, et al. Prognostic factors for medulloblastoma. Int J Radiat Oncol Biol Phys. 2000;47: 573-584.
3. Perez-Martinez A, Lassaletta A, Gonzalez-Vicent M, et al. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol. 2005;71: 33-38.
4. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology. 1969;93: 1351-1359.
5. Ray A, Ho M, Ma J, et al. A clinicobiological model predicting survival in medulloblastoma. Clin Cancer Res. 2004;10: 7613-7620.
6. Gilbertson R, Wickramasinghe C, Hernan R, et al. Clinical and molecular stratification of disease risk in medulloblastoma. Br J Cancer. 2001;85: 705-712.
7. Gajjar A, Hernan R, Kocak M, et al. Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22: 984-993.
8. Hara J, Osugi Y, Ohta H, et al. Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric solid tumors. Bone Marrow Transplant. 1998;22: 7-12.
9. Schiffer D, Cavalla P, Chio A, et al. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol. 1994;87: 362-370.
10. Guruangan S, Dunkel IJ, Goldman S, et al. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. J Clin Oncol. 1998;16: 2486-2493.
11. Dunkel IJ, Boyett JM, Yates A, et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children’s Cancer Group. J Clin Oncol. 1998;16: 222-228.
12. Graham ML, Herndon JE 2nd, Casey JR, et al. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors. J Clin Oncol. 1997;15: 1814-1823.
13. Mahoney DH Jr, Strother D, Camitta B, et al. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol. 1996;14: 382-388.
14. Kalifa C, Hartmann O, Demeocq F, et al. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant. 1992;9: 227-233.
15. Gururangan S, Krauser J, Watral MA, et al. Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. Neuro Oncol. 2008;10: 745-751.
16. Gardner SL. Application of stem cell transplant for brain tumors. Pediatr Transplant. 2004;8(suppl 5): 28-32.
17. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998;16: 210-221.
18. MacDonald TJ, Brown KM, LaFleur B, et al. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. Nat Genet. 2001;29: 143-152.
19. Ridola V, Grill J, Doz F, et al. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. Cancer. 2007;110: 156-163.
20. Valteau-Couanet D, Fillipini B, Benhamou E, et al. High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy. Bone Marrow Transplant. 2005;36: 939-945.
21. Stearns D, Chaudhry A, Abel TW, et al. c-myc overexpression causes anaplasia in medulloblastoma. Cancer Res. 2006;66: 673-681.
22. Contessa JN, Hamstra DA. Revoking the privilege: targeting HER2 in the central nervous system. Mol Pharmacol. 2008;73: 271-273.
23. Entz-Werle N, Velasco V, Neuville A, et al. Do medulloblastoma tumors meet the Food and Drug Administration criteria for anti-erbB2 therapy with trastuzumab? Pediatr Blood Cancer. 2008;50: 163-166.